0.000USD0.000Pre-market 07/24, 09:30 (ET)
129.82MMarket Cap
LossP/E TTM
Karyopharm Therapeutics Inc
KPTI Balance Sheet
You can check out the annual or quarterly balance sheets of Karyopharm Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing KPTI stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Karyopharm Therapeutics Inc Have?
In its most recent quarterly, Karyopharm Therapeutics Inc had 90.85M in cash and cash equivalents.
What Are Karyopharm Therapeutics Inc's Total Assets?
As of the latest reported quarter, Karyopharm Therapeutics Inc's total assets were 108.42M, consisting of 103.15M in current assets and 5.27M in non-current assets.
How Much Shareholders' Equity Does Karyopharm Therapeutics Inc Have?
Karyopharm Therapeutics Inc reported -292.93M in total shareholders' equity as of the latest reported quarter.